Inhibition of TCA cycle improves the anti-PD-1 immunotherapy efficacy in melanoma cells via ATF3-mediated PD-L1 expression and glycolysis

author
created [InstanceEdit:9911970] Tiwari, Krishna, 2024-06-06
dbId 9911895
displayName Inhibition of TCA cycle improves the anti-PD-1 immunotherapy efficacy in melanoma cells via ATF3-mediated PD-L1 expression and glycolysis
journal J Immunother Cancer
pubMedIdentifier 37678921
schemaClass LiteratureReference
title Inhibition of TCA cycle improves the anti-PD-1 immunotherapy efficacy in melanoma cells via ATF3-mediated PD-L1 expression and glycolysis
url http://www.ncbi.nlm.nih.gov/pubmed/37678921
volume 11
year 2023
Cite Us!